Moving from supported to independent living: what are the barriers and facilitators for individuals with psychosis?

Functional recovery Markov chain modeling Schizophrenia Sheltered housing Supported housing

Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
08 Jan 2024
Historique:
received: 09 05 2023
accepted: 30 10 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: aheadofprint

Résumé

Living independently, as opposed to in sheltered housing or with caregivers, is an important aim in the recovery of individuals with psychosis, but the transition to independence can be challenging. This study aims to investigate how individuals with psychosis move between living arrangements and to identify the barriers and facilitators of moving towards independence. The living arrangements of 1119 individuals with non-affective psychosis from the Genetic Risk and Outcome of Psychosis study were assessed at baseline, at three- and six-year follow-ups and further categorized as either supported (sheltered housing or with parents) or independent (single or with partner/family). We estimated the probabilities of transitioning between the living statuses and investigated the influence of demographic characteristics, symptomatology, cognition, social support, and premorbid social adjustment on transition using Markov chain modelling. The majority of individuals living in supported housing remained there during the six-year follow-up period (~ 60%). The likelihood of moving from supported to independent living was twice as high for participants who were younger, five-to-six times higher for women, twice as high for individuals with better overall cognition, and five times higher for those with a course of low positive symptoms. This study highlights that a large group of individuals with psychosis in supported housing is unlikely to move to independent living. Older men with cognitive impairments and who show continuous severe positive symptoms are the least likely to move living independently. Tailored interventions for these at-risk individuals could increase their chances of moving to independent living.

Identifiants

pubmed: 38189942
doi: 10.1007/s00127-023-02586-x
pii: 10.1007/s00127-023-02586-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Behrooz Z Alizadeh (BZ)
Therese van Amelsvoort (T)
Agna A Bartels-Velthuis (AA)
Richard Bruggeman (R)
Wiepke Cahn (W)
Lieuwe de Haan (L)
Frederike Schirmbeck (F)
Claudia J P Simons (CJP)
Jim van Os (J)

Informations de copyright

© 2024. The Author(s).

Références

Hudson CG (2016) A model of deinstitutionalization of psychiatric care across 161 nations: 2001–2014. Int J Ment Health 45:135–153. https://doi.org/10.1080/00207411.2016.1167489
doi: 10.1080/00207411.2016.1167489
Jose D, Ramachandra LK et al (2015) Consumer perspectives on the concept of recovery in schizophrenia: a systematic review. Asian J Psychiatr 14:13–18. https://doi.org/10.1016/J.AJP.2015.01.006
doi: 10.1016/J.AJP.2015.01.006 pubmed: 25703654
Fakhoury WKH, Priebe S, Quraishi M (2005) Goals of new long-stay patients in supported housing: a UK study. Int J Soc Psychiatry 51:45–54. https://doi.org/10.1177/0020764005053273
doi: 10.1177/0020764005053273 pubmed: 15864974
Browne G, Courtney M (2005) Housing, social support and people with schizophrenia: a grounded theory study. Issues Ment Health Nurs 26:311–326. https://doi.org/10.1080/01612840590915694
doi: 10.1080/01612840590915694 pubmed: 16020049
Fossey E, Harvey C, McDermott F (2019) Housing and support narratives of people experiencing mental health issues: making my place, my home. Front Psychiatry. https://doi.org/10.3389/FPSYT.2019.00939
doi: 10.3389/FPSYT.2019.00939 pubmed: 31998158
Santesteban-Echarri O, Paino M, Rice S et al (2017) Predictors of functional recovery in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies. Clin Psychol Rev 58:59–75. https://doi.org/10.1016/J.CPR.2017.09.007
doi: 10.1016/J.CPR.2017.09.007
Brekke J, Kay DD, Lee KS, Green MF (2005) Biosocial pathways to functional outcome in schizophrenia. Schizophr Res 80:213–225. https://doi.org/10.1016/j.schres.2005.07.008
doi: 10.1016/j.schres.2005.07.008 pubmed: 16137859
De Girolamo G, Candini V, Buizza C et al (2014) Is psychiatric residential facility discharge possible and predictable? A multivariate analytical approach applied to a prospective study in Italy. Soc Psychiatry Psychiatr Epidemiol 49:157–167. https://doi.org/10.1007/s00127-013-0705-z
doi: 10.1007/s00127-013-0705-z pubmed: 23712514
Dickerson FB, Ringel N, Parente F (1999) Predictors of residential independence among outpatients with schizophrenia. Psychiatr Serv 50:515–519. https://doi.org/10.1176/ps.50.4.515
doi: 10.1176/ps.50.4.515 pubmed: 10211733
Auslander LA, Lindamer LL, Delapena J et al (2001) A comparison of community-dwelling older schizophrenia patients by residential status. Acta Psychiatr Scand 103:380–386. https://doi.org/10.1034/j.1600-0447.2001.00262.x
doi: 10.1034/j.1600-0447.2001.00262.x pubmed: 11380308
Palmer BW, Heaton RK, Gladsjo JA et al (2002) Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr Res 55:205–215. https://doi.org/10.1016/S0920-9964(01)00218-3
doi: 10.1016/S0920-9964(01)00218-3 pubmed: 12048144
Hofer A, Baumgartner S, Bodner T et al (2005) Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry 20:395–402. https://doi.org/10.1016/j.eurpsy.2005.02.006
doi: 10.1016/j.eurpsy.2005.02.006 pubmed: 16171654
Levitt JJ, Shenton ME, McCarley RW et al (1994) Premorbid adjustment in schizophrenia: implications for psychosocial and ventricular pathology. Schizophr Res 12:159–168. https://doi.org/10.1016/0920-9964(94)90073-6
doi: 10.1016/0920-9964(94)90073-6 pubmed: 8043526
Palmer BW, Dawes SE, Heaton RK (2009) What do we know about neuropsychological aspects of schizophrenia? Neuropsychol Rev 19:365–384. https://doi.org/10.1007/s11065-009-9109-y
doi: 10.1007/s11065-009-9109-y pubmed: 19639412 pmcid: 2745531
Habtewold TD, Rodijk LH, Liemburg EJ et al (2020) A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits. Transl Psychiatry 10:1–24. https://doi.org/10.1038/s41398-020-00919-x
doi: 10.1038/s41398-020-00919-x
Korver N, Quee PJ, Boos HBM et al (2012) Genetic Risk and Outcome of Psychosis (GROUP), A multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res 21:205–221. https://doi.org/10.1002/mpr.1352
doi: 10.1002/mpr.1352 pubmed: 22419500 pmcid: 6878383
Meijer J, Simons CJP, Quee PJ et al (2012) Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents. Acta Psychiatr Scand 125:66–76. https://doi.org/10.1111/j.1600-0447.2011.01777.x
doi: 10.1111/j.1600-0447.2011.01777.x pubmed: 22013907
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276. https://doi.org/10.1093/schbul/13.2.261
doi: 10.1093/schbul/13.2.261 pubmed: 3616518
Van Der Meer L, Kaiser S, Castelein S (2021) Negative symptoms in schizophrenia: reconsidering evidence and focus in clinical trials. Br J Psychiatry 219:359–360. https://doi.org/10.1192/bjp.2021.66
doi: 10.1192/bjp.2021.66 pubmed: 35048858
Stiekema APM, Liemburg EJ, Van Der Meer L et al (2016) Confirmatory factor analysis and differential relationships of the two subdomains of negative symptoms in chronically ill psychotic patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0149785
doi: 10.1371/journal.pone.0149785 pubmed: 26895203 pmcid: 4760738
Cannon-Spoor HE, Potkin SG, Jed Wyatt R (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8:470–480. https://doi.org/10.1093/schbul/8.3.470
doi: 10.1093/schbul/8.3.470 pubmed: 7134891
Slade M, Beck A, Bindman J et al (1999) Routine clinical outcome measures for patients with severe mental illness: CANSAS and HoNOS. Br J Psychiatry 174:404–408. https://doi.org/10.1192/BJP.174.5.404
doi: 10.1192/BJP.174.5.404 pubmed: 10616605
Islam MA, Habtewold TD, van Es FD et al (2018) Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings. Acta Psychiatr Scand 138:591–604. https://doi.org/10.1111/acps.12961
doi: 10.1111/acps.12961 pubmed: 30242827 pmcid: 6220939
Habtewold TD, Tiles-Sar N, Liemburg EJ et al (2023) Six-year trajectories and associated factors of positive and negative symptoms in schizophrenia patients, siblings, and controls: Genetic Risk and Outcome of Psychosis (GROUP) study. Sci Rep. 13(1):9391. https://doi.org/10.1038/s41598-023-36235-9
doi: 10.1038/s41598-023-36235-9 pubmed: 37296301 pmcid: 10256804
Tiles-Sar N, Habtewold TD, Liemburg EJ et al (2023) Understanding lifelong factors and prediction models of social functioning after psychosis onset using the large-scale GROUP Cohort study. Schizophr Bull. https://doi.org/10.1093/schbul/sbad046
doi: 10.1093/schbul/sbad046 pubmed: 37104875 pmcid: 10686366
Jackson CH (2011) Multi-state models for panel data: The MSM package for R. J Stat Softw 38:1–28. https://doi.org/10.18637/jss.v038.i08
doi: 10.18637/jss.v038.i08
Core Development Team R (2020) A language and environment for statistical computing. R foundation for statistical computing 2: https://www.R-project.org
Castelein S, Timmerman ME, PHAMOUS investigators, van der Gaag M, Visser E (2021) Clinical, societal and personal recovery in schizophrenia spectrum disorders across time: states and annual transitions. Br J Psychiatry. 219(1):401–408. https://doi.org/10.1192/bjp.2021.48
doi: 10.1192/bjp.2021.48 pubmed: 35048855 pmcid: 8529640
Barnes S, Carson J, Gournay K (2022) Enhanced supported living for people with severe and persistent mental health problems: a qualitative investigation. Health Soc Care Commun 30(6):e4293–e4302. https://doi.org/10.1111/hsc.13822
doi: 10.1111/hsc.13822
Bodén R, Abrahamsson T, Holm G, Borg J (2014) Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophrenia. Nord J Psychiatry 68:282–288. https://doi.org/10.3109/08039488.2013.830771
doi: 10.3109/08039488.2013.830771 pubmed: 24050122
Tan BL (2009) Profile of cognitive problems in schizophrenia and implications for vocational functioning. Aust Occup Ther J 56:220–228. https://doi.org/10.1111/j.1440-1630.2008.00759.x
doi: 10.1111/j.1440-1630.2008.00759.x pubmed: 20854522
Fett AKJ, Viechtbauer W, de Dominguez MG et al (2011) The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev 35:573–588. https://doi.org/10.1016/j.neubiorev.2010.07.001
doi: 10.1016/j.neubiorev.2010.07.001 pubmed: 20620163
Gogos A, Sbisa AM, Sun J et al (2015) A role for estrogen in schizophrenia: clinical and preclinical findings. Int J Endocrinol. https://doi.org/10.1155/2015/615356
doi: 10.1155/2015/615356 pubmed: 26491441 pmcid: 4600562
Comacchio C, Lasalvia A, Bonetto C et al (2020) Gender and 5-years course of psychosis patients: focus on clinical and social variables. Arch Women’s Mental Health 23:63–70. https://doi.org/10.1007/s00737-019-0945-3
doi: 10.1007/s00737-019-0945-3
Lysaker PH, Pattison ML, Leonhardt BL et al (2018) Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatry 17:12–23. https://doi.org/10.1002/wps.20508
doi: 10.1002/wps.20508 pubmed: 29352540 pmcid: 5775127
Kane JM, Agid O, Baldwin ML et al (2019) Clinical guidance on the identification and management of treatment-resistant schizophrenia. J Clin Psychiatry. https://doi.org/10.4088/JCP.18COM12123
doi: 10.4088/JCP.18COM12123 pubmed: 31536686
Bitter N, Roeg D, van Nieuwenhuizen C, van Weeghel J (2020) Recovery in supported accommodations: a scoping review and synthesis of interventions for people with severe mental illness. Commun Ment Health J 56:1053–1076. https://doi.org/10.1007/s10597-020-00561-3
doi: 10.1007/s10597-020-00561-3
Vita A, Barlati S, Ceraso A et al (2021) Effectiveness, core elements, and moderators of response of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat 78:848–858. https://doi.org/10.1001/jamapsychiatry.2021.0620
doi: 10.1001/jamapsychiatry.2021.0620
Stiekema APM, van Dam MT, Bruggeman R et al (2020) Facilitating recovery of daily functioning in people with a severe mental illness who need longer-term intensive psychiatric services: results from a cluster randomized controlled trial on cognitive adaptation training delivered by nurses. Schizophr Bull 46:1259–1268. https://doi.org/10.1093/schbul/sbz135
doi: 10.1093/schbul/sbz135 pubmed: 32144418 pmcid: 7505172
John A, Gandhi S, Prasad MK, Manjula M (2022) Effectiveness of IADL interventions to improve functioning in persons with Schizophrenia: a systematic review. Int J Soc Psychiatry 68(3):500–513. https://doi.org/10.1177/00207640211060696
doi: 10.1177/00207640211060696 pubmed: 34802260

Auteurs

Anika Poppe (A)

Department of Clinical and Developmental Neuropsychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS, Groningen, The Netherlands. a.poppe@rug.nl.
Department of Rehabilitation, Lentis Psychiatric Institute, Zuidlaren, The Netherlands. a.poppe@rug.nl.

Natalia Tiles-Sar (N)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Psychiatry, Rob Giel Research Center, University Medical Center Groningen, University Center for Psychiatry, University of Groningen, Groningen, The Netherlands.

Stefan R A Konings (SRA)

Department of Psychiatry, Rob Giel Research Center, University Medical Center Groningen, University Center for Psychiatry, University of Groningen, Groningen, The Netherlands.
Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Tesfa Dejenie Habtewold (TD)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Richard Bruggeman (R)

Department of Psychiatry, Rob Giel Research Center, University Medical Center Groningen, University Center for Psychiatry, University of Groningen, Groningen, The Netherlands.

Behrooz Z Alizadeh (BZ)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Lisette van der Meer (L)

Department of Clinical and Developmental Neuropsychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS, Groningen, The Netherlands.
Department of Rehabilitation, Lentis Psychiatric Institute, Zuidlaren, The Netherlands.

Classifications MeSH